ammonium hydroxide has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eagles, CJ; Kendall, MJ | 1 |
1 trial(s) available for ammonium hydroxide and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
| Article | Year |
|---|---|
The effects of combined treatment with beta 1-selective receptor antagonists and lipid-lowering drugs on fat metabolism and measures of fatigue during moderate intensity exercise: a placebo-controlled study in healthy subjects.
Topics: Adrenergic beta-Antagonists; Adult; Ammonia; Analysis of Variance; Anticholesteremic Agents; Atenolol; Bezafibrate; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Energy Metabolism; Exercise; Fatigue; Fatty Acids, Monounsaturated; Fatty Acids, Nonesterified; Female; Fluvastatin; Heart Rate; Humans; Hypolipidemic Agents; Indoles; Lactic Acid; Lipids; Male; Oxygen Consumption; Triglycerides | 1997 |